A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Iterum Therapeutics Plc’s current trading price is -25.20% away from its 52-week high, while its distance from the 52-week low is 200.64%. The stock’s price range for this time frame has been between $0.62 and $2.50. The trading volume of the company’s shares in the Healthcare reached around 0.75 million for the day, which was evidently higher than the average daily volume of 0.61 million over the last three months.
Iterum Therapeutics Plc had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of $2.50 on 11/27/23, while the lowest price during the same period was $0.62 on 10/25/23.
How Financial Performance Impacts Market Capitalization
Iterum Therapeutics Plc (ITRM) has experienced a quarterly decline of -5.08% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 25.10M and boasts a workforce of 14 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.6389, with a change in price of +1.1295. Similarly, Iterum Therapeutics Plc recorded 471,363 in trading volume during the last 100 days, posting a change of +152.53%.
ITRM Stock Stochastic Average
Iterum Therapeutics Plc’s raw stochastic average for the past 50 days is currently at 58.05%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 88.46%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 74.76% and 76.23%, respectively.
ITRM Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The metric has seen a significant loss of -5.08% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 161.98%. Over the past 30 days, the price of ITRM has fallen by 47.83%. And in the last five days, it has surged by 17.61%.
